Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionTwo Sigma Securities, Llc
Latest Disclosed Ownership1,135 shares
Latest Disclosed Value $ 876,946
Two Sigma Securities, Llc ownership in REGN / Regeneron Pharmaceuticals, Inc.

On May 15, 2026 - Two Sigma Securities, Llc filed a 13F-HR form disclosing ownership of 1,135 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $876,946 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 0 shares of Regeneron Pharmaceuticals, Inc..

Two Sigma Securities, Llc has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,135 1,135 877 0.1019
2026-02-17 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -445 -100.00 0 -100.00
2025-11-14 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 445 -1,523 -77.39 250 -75.80 0.0369
2025-08-14 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,968 1,024 108.47 1,033 72.74 0.1275
2025-05-15 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 944 -550 -36.81 599 -43.80 0.0908
2025-02-14 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,494 -206 -12.12 1,064 -40.46 0.1411
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,700 1,700 1,787 0.0302
2024-05-15 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -7,967 -100.00 0 -100.00
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 7,967 7,681 2,685.66 6,997 2,877.45 0.0676
2023-11-14 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 286 -4,287 -93.75 235 -92.85 0.0025
2023-08-14 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,573 -1,490 -24.58 3,286 -34.05 0.0489
2023-05-15 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,063 6,063 4,982 0.0999
2023-02-14 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -1,171 -100.00 0 -100.00
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,171 -99 -7.80 807 7.46 0.0244
2022-08-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,270 -4,375 -77.50 751 -80.95 0.0266
2022-05-16 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,645 3,034 116.20 3,943 139.11 0.1388
2022-02-14 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,611 1,850 243.10 1,649 257.70 0.0718
2021-11-15 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 761 -493 -39.31 461 -34.14 0.0135
2021-08-16 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,254 161 14.73 700 35.40 0.0210
2021-05-17 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,093 -441 -28.75 517 -30.23 0.0286
2021-02-16 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,534 866 129.64 741 98.13 0.0175
2020-11-16 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 668 -6 -0.89 374 -10.95 0.0076
2020-09-10 2020-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 674 674 0.90 420 12.30 0.0094
2020-08-14 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 9,674 9,674 6,033 96,273.9292
2020-05-15 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -1,032 -100.00 0 -100.00
2020-02-14 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,032 -3,629 -77.86 387 -70.07 0.0026
2019-11-14 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,661 3,680 375.13 1,293 321.17 0.0118
2019-08-14 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 981 981 -78.95 307 -76.26 0.0032
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -2,397 -100.00 0 -100.00
2019-02-14 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,397 -3,209 -57.24 895 -60.49 0.0109
2018-11-14 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,606 -680 -10.82 2,265 4.43 0.0147
2018-08-14 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 6,286 3,209 104.29 2,169 104.62 0.0108
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,077 2,172 240.00 1,060 211.76 0.0059
2018-02-14 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 905 -134 -12.90 340 -26.88 0.0091
2017-11-14 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,039 279 36.71 465 24.66 0.0425
2017-08-14 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 760 760 -26.85 373 -19.78 0.0710
2017-02-14 2016-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -627 -100.00 0 -100.00
2016-11-14 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 627 627 0.00 252 0.0859
2016-05-16 2016-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -505 -100.00 0 -100.00
2016-02-16 2015-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 505 505 274 0.3288
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-15 2025-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F REGENERON PHARMACEUTICALS COM Call 800 -68.00 570 -78.35 n/a n/a n/a
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICALS COM Call 2,500 78.57 2,628 78.65 n/a n/a n/a
2024-08-14 2024-06-30 13F REGENERON PHARMACEUTICALS COM Call 1,400 -72.55 1,471 -70.03 n/a n/a n/a
2024-05-15 2024-03-31 13F REGENERON PHARMACEUTICALS COM Call 5,100 264.29 4,909 299.35 n/a n/a n/a
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM Call 1,400 -36.36 1,230 -32.10 n/a n/a n/a
2023-11-14 2023-09-30 13F REGENERON PHARMACEUTICALS COM Call 2,200 100.00 1,811 129.11 n/a n/a n/a
2023-08-14 2023-06-30 13F REGENERON PHARMACEUTICALS COM Call 1,100 -86.75 790 -88.41 n/a n/a n/a
2023-05-15 2023-03-31 13F REGENERON PHARMACEUTICALS COM Call 8,300 2,666.67 6,820 3,056.94 n/a n/a n/a
2023-02-14 2022-12-31 13F REGENERON PHARMACEUTICALS COM Call 300 -92.11 216 -91.75 n/a n/a n/a
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM Call 3,800 2,618 n/a n/a n/a
2022-08-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F REGENERON PHARMACEUTICALS COM Call 1,000 698 n/a n/a n/a
2022-02-14 2021-12-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F REGENERON PHARMACEUTICALS COM Call 1,500 15.38 908 25.07 n/a n/a n/a
2021-08-16 2021-06-30 13F REGENERON PHARMACEUTICALS COM Call 1,300 726 n/a n/a n/a
2021-05-17 2021-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F REGENERON PHARMACEUTICALS COM Call 5,200 188.89 2,512 149.21 n/a n/a n/a
2020-11-16 2020-09-30 13F REGENERON PHARMACEUTICALS COM Call 1,800 -60.87 1,008 -64.87 n/a n/a n/a
2020-09-10 2020-06-30 13F/A REGENERON PHARMACEUTICALS COM Call 4,600 109.09 2,869 167.13 n/a n/a n/a
2020-05-15 2020-03-31 13F REGENERON PHARMACEUTICALS COM Call 2,200 -92.67 1,074 -90.47 n/a n/a n/a
2020-02-14 2019-12-31 13F REGENERON PHARMACEUTICALS COM Call 30,000 183.02 11,264 283.13 n/a n/a n/a
2019-11-14 2019-09-30 13F REGENERON PHARMACEUTICALS CALL Call 10,600 -38.01 2,940 -45.07 n/a n/a n/a
2019-08-14 2019-06-30 13F REGENERON PHARMACEUTICALS COM Call 17,100 8.92 5,352 -16.98 n/a n/a n/a
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM Call 15,700 -18.23 6,447 -10.10 n/a n/a n/a
2019-02-14 2018-12-31 13F REGENERON PHARMACEUTICALS COM Call 19,200 -27.55 7,171 -33.03 n/a n/a n/a
2018-11-14 2018-09-30 13F REGENERON PHARMACEUTICALS COM Call 26,500 -21.36 10,707 -7.90 n/a n/a n/a
2018-08-14 2018-06-30 13F REGENERON PHARMACEUTICALS COM Call 33,700 -6.91 11,626 -6.74 n/a n/a n/a
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM Call 36,200 2,485.71 12,466 2,269.96 n/a n/a n/a
2018-02-14 2017-12-31 13F REGENERON PHARMACEUTICALS COM Call 1,400 526 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-15 2025-03-31 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F REGENERON PHARMACEUTICALS COM Put 300 -83.33 214 -88.74 n/a n/a n/a
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICALS COM Put 1,800 -57.14 1,892 -57.14 n/a n/a n/a
2024-08-14 2024-06-30 13F REGENERON PHARMACEUTICALS COM Put 4,200 -6.67 4,414 1.92 n/a n/a n/a
2024-05-15 2024-03-31 13F REGENERON PHARMACEUTICALS COM Put 4,500 18.42 4,331 29.79 n/a n/a n/a
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM Put 3,800 -19.15 3,338 -13.71 n/a n/a n/a
2023-11-14 2023-09-30 13F REGENERON PHARMACEUTICALS COM Put 4,700 95.83 3,868 124.30 n/a n/a n/a
2023-08-14 2023-06-30 13F REGENERON PHARMACEUTICALS COM Put 2,400 -73.03 1,724 -76.42 n/a n/a n/a
2023-05-15 2023-03-31 13F REGENERON PHARMACEUTICALS COM Put 8,900 7,313 n/a n/a n/a
2023-02-14 2022-12-31 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM Put 1,000 689 n/a n/a n/a
2022-08-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F REGENERON PHARMACEUTICALS COM Put 6,100 1,425.00 4,260 1,583.79 n/a n/a n/a
2022-02-14 2021-12-31 13F REGENERON PHARMACEUTICALS COM Put 400 -50.00 253 -47.73 n/a n/a n/a
2021-11-15 2021-09-30 13F REGENERON PHARMACEUTICALS COM Put 800 14.29 484 23.79 n/a n/a n/a
2021-08-16 2021-06-30 13F REGENERON PHARMACEUTICALS COM Put 700 391 n/a n/a n/a
2021-05-17 2021-03-31 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F REGENERON PHARMACEUTICALS COM Put 2,200 22.22 1,063 5.46 n/a n/a n/a
2020-11-16 2020-09-30 13F REGENERON PHARMACEUTICALS COM Put 1,800 -59.09 1,008 -63.27 n/a n/a n/a
2020-09-10 2020-06-30 13F/A REGENERON PHARMACEUTICALS COM Put 4,400 633.33 2,744 836.52 n/a n/a n/a
2020-05-15 2020-03-31 13F REGENERON PHARMACEUTICALS COM Put 600 -96.89 293 -95.96 n/a n/a n/a
2020-02-14 2019-12-31 13F REGENERON PHARMACEUTICALS COM Put 19,300 96.94 7,247 166.53 n/a n/a n/a
2019-11-14 2019-09-30 13F REGENERON PHARMACEUTICALS PUT Put 9,800 -47.31 2,719 -53.30 n/a n/a n/a
2019-08-14 2019-06-30 13F REGENERON PHARMACEUTICALS COM Put 18,600 72.22 5,822 31.27 n/a n/a n/a
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM Put 10,800 24.14 4,435 36.50 n/a n/a n/a
2019-02-14 2018-12-31 13F REGENERON PHARMACEUTICALS COM Put 8,700 -58.77 3,249 -61.89 n/a n/a n/a
2018-11-14 2018-09-30 13F REGENERON PHARMACEUTICALS COM Put 21,100 -19.77 8,525 -6.04 n/a n/a n/a
2018-08-14 2018-06-30 13F REGENERON PHARMACEUTICALS COM Put 26,300 25.24 9,073 25.46 n/a n/a n/a
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM Put 21,000 7,232 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.